• E-64d: Applied Workflows for Cysteine Protease Inhibition Re

  2026-07-13

  Harnessing E-64d’s membrane-permeable, irreversible inhibition, researchers can dissect calpain and cathepsin function in apoptosis, neuroprotection, and beyond. This guide delivers evidence-backed protocol parameters, troubleshooting strategies, and an integration of recent breakthroughs to elevate your cysteine protease assays.

• Coptisine Regulates SIRT1 Ubiquitination to Alleviate PCOS i

  2026-07-12

  This study demonstrates that Jiao-tai-wan and its component coptisine alleviate polycystic ovary syndrome (PCOS) in DHEA-induced rat models by suppressing SIRT1 ubiquitination and regulating mitochondrial cholesterol import. The mechanistic insights clarify how coptisine restores ovarian steroidogenesis and mitochondrial dynamics, offering translational potential for PCOS research.

• Entecavir (BMS200475): Translational Insights for HBV Therap

  2026-07-10

  Explore Entecavir's unique role in suppressing chronic hepatitis B virus replication, including its effectiveness against resistant strains and translational implications for advanced therapy. This article delivers a rigorous, reference-backed analysis distinct from existing guides.

• Dronedarone (Multaq): Mechanistic Insights for Precision Atr

  2026-07-09

  Discover how Dronedarone (Multaq) enables next-generation atrial fibrillation research through mechanistic clarity and advanced pharmacology. This article delivers a deeper exploration of ion channel selectivity, translational opportunities, and practical assay choices—distinct from existing protocol-driven guides.

• 3X (DYKDDDDK) Peptide: Pushing Boundaries in Protein Science

  2026-07-09

  Explore how the 3X (DYKDDDDK) Peptide—anchored in mechanistic insight and translational strategy—redefines recombinant protein workflows. This thought-leadership piece bridges cutting-edge affinity purification, immunodetection, and structural biology, offering actionable guidance for researchers aiming to achieve reproducibility and clinical impact.

• Tubastatin A Attenuates Myocardial Damage After Cardiac Arre

  2026-07-08

  A recent preclinical study reveals that Tubastatin A, a selective HDAC6 inhibitor, significantly reduces post-resuscitation myocardial injury in a porcine model of cardiac arrest by inhibiting GSDME-mediated pyroptosis and MLKL-mediated necroptosis. These findings provide mechanistic insight and translational potential for targeting epigenetic regulators in acute cardiac injury.

• Superoxide Dismutase (SOD) Activity Assay Kit: Protocol & QC

  2026-07-08

  The Superoxide Dismutase (SOD) Activity Assay Kit (SKU: K2035) offers a sensitive, rapid, and quantitative method for measuring SOD enzyme activity in biological samples. It streamlines detection of antioxidative defenses in research on oxidative stress, but should not be used for clinical diagnostics. This guide clarifies practical assay setup, protocol considerations, and troubleshooting within research boundaries.

• Tubastatin A: HDAC6 Inhibitor Workflows in Cardiac and Cance

  2026-07-07

  Tubastatin A offers unmatched selectivity for HDAC6, enabling nuanced dissection of cell death and inflammation pathways in both cardiac injury and cancer models. This article delivers stepwise protocols, troubleshooting strategies, and highlights translational innovations arising from recent preclinical studies—empowering researchers to maximize reproducibility and mechanistic insight.

• AMPK Modulates M1 Macrophage Polarization in Obesity-Related

  2026-07-07

  This study uncovers how AMPK activation attenuates airway inflammation in obesity-related asthma by suppressing M1 macrophage polarization through the JAK2/STAT3 pathway. These findings highlight AMPK as a potential therapeutic target and illuminate underlying immunometabolic mechanisms driving refractory asthma in obese individuals.

• JNJ-10198409: Precision Platelet-Derived Growth Factor Recep

  2026-07-06

  JNJ-10198409, supplied by APExBIO, empowers cancer and fibrosis researchers with robust, nanomolar-potency PDGF-BB receptor inhibition and is ideal for dissecting angiogenesis and tumor growth mechanisms. Its ATP-competitive mechanism enables reproducible, dose-dependent modulation in both standard and advanced kinase pathway assays.

• Exo1: Mechanistic Inhibition of Exocytic Pathways in Researc

  2026-07-06

  Exo1 (methyl 2-(4-fluorobenzamido)benzoate) is a preclinical, selective chemical inhibitor used in membrane trafficking and exocytosis studies. It achieves acute inhibition of ER-to-Golgi transport by a distinctive ARF1-displacement mechanism, enabling precise dissection of exocytic pathways in cellular models.

• Cy7 NHS Ester: Protocols for Sensitive Near-Infrared Protein

  2026-07-05

  Cy7 NHS ester addresses challenges in efficient, low-quenching labeling of proteins and peptides for near-infrared fluorescent imaging. Its water solubility and sulfonation make it suitable for labeling sensitive biomolecules without harsh organic solvents, but it is not recommended for long-term storage in solution or in incompatible buffers.

• Tubastatin A: HDAC6 Inhibition for Translational Breakthroug

  2026-07-04

  This thought-leadership article explores how Tubastatin A, a highly selective HDAC6 inhibitor from APExBIO, is redefining translational research across cancer, cardiovascular, and inflammatory models. Drawing on recent mechanistic findings, including its role in protecting post-resuscitation myocardium, the discussion blends molecular insight with actionable guidance for researchers seeking to bridge basic discovery and clinical impact.

• Cardamomin Mitigates Oxidative Damage and Ischemic Stroke vi

  2026-07-03

  This study demonstrates that cardamomin, a chalcone from Amomum villosum, protects neural cells against oxidative damage both in vitro and in rat models of cerebral ischemic stroke. By activating the NRF2 pathway and inhibiting cell death mechanisms, cardamomin offers mechanistic insight into potential neuroprotective therapies.

• CCK-8s Activates NOX4–PGC-1α–PPARα/γ Signaling to Promote AN

  2026-07-03

  This study uncovers a mechanistic link between sulfated cholecystokinin octapeptide (CCK-8s) and enhanced atrial natriuretic peptide (ANP) secretion via a NOX4–PGC-1α–PPARα/PPARγ signaling cascade in isolated rat atria. The findings clarify how CCK-8s modulates cardiac signaling and oxidative responses, with implications for cardiovascular and inflammation research.

17082 records 5/1139 page Previous Next 12345 下5页 Last page